Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 7/20 | 0.63 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.62 |
| ▸ | PTH1R | Q03431 | 1/20 | 0.60 |
| ▸ | GLP1R | P43220 | 7/20 | 0.60 |
| ▸ | GCGR | P47871 | 3/20 | 0.60 |
| ▸ | CALCA | P06881 | 1/20 | 0.59 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31182780 | 0.91 | C5AR1 (0.66) | CXCR4GLP1RGCGR | |
| SCHEMBL29922398 | 0.91 | GLP1R (0.69) | CXCR4RXFP1PTH1RGLP1RGCGR | |
| SCHEMBL30536952 | 0.91 | GLP1R (0.70) | PTH1RGLP1RGCGR | |
| SCHEMBL29523146 | 0.90 | RXFP1 (0.64) | CXCR4RXFP1PTH1R | |
| SCHEMBL30029352 | 0.89 | GLP1R (0.67) | CXCR4RXFP1PTH1RGLP1RGCGR | |
| SCHEMBL30750752 | 0.89 | GLP1R (0.73) | GLP1RGCGR | |
| SCHEMBL31020887 | 0.89 | CXCR4 (0.68) | CXCR4RXFP1GLP1RGCGRKEAP1 | |
| SCHEMBL30874225 | 0.89 | GLP1R (0.73) | PTH1RGLP1RGCGR | |
| SCHEMBL30029354 | 0.88 | GLP1R (0.68) | CXCR4PTH1RGLP1RGCGR | |
| Cecropin B SCHEMBL29355118 | 0.88 | KEAP1 (0.69) | RXFP1PTH1RGLP1RGCGRKEAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114344451-B | Application of Reg4 antibacterial peptide in treatment of pseudomonas aeruginosa infectious pneumonia | 上海市肺科医院 | 2023-09-26 | — | — | CN | disclosed |
| CN-114409758-A | Application of Reg4 antibacterial peptide in treatment of pathogenic escherichia coli infection | 上海市儿科医学研究所 | 2022-04-29 | — | — | CN | disclosed |